Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2017.327 | A randomized, double-masked, clinical trial comparing extended vs standard endonasal dacryocystorhinostomy (ExStEND) for primary acquired nasolacrimal duct obstruction |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2017.025 | 3D-printed Surgical Instruments and Orbital Models (3SIOM) |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2016.038 | Mitomycin, Intubation vs No adjuvant In MUcosal-preserving Mechanical endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction (MINIMUM endonasal DCR for PANLDO) |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2014.530 | Prevalance and progression of open angle glaucoma and ocular hypertension in thyroid-associated orbitopathy (TAO) patients in the Hong Kong Chinese population | Dr. CHONG Kelvin Kam Lung |
| 2016.325 | Combined Radiotherapy and Intravenous Steroid for Early Progressive Thyroid Eye Disease |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2017.037 | Ocular Hypertension and Glaucoma in Thyroid Associated Orbitopathy |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2017.151 | Registry of oculoplastic and adnexal disorders (ROAD) |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2017.433 | Identification of new susceptibility and disease-causing genes in the pathogenesis and prediction of thyroid associated orbitopathy (TAO) |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2017.570 | IgG4-related ophthalmic disease (IgG4-ROD) in Hong Kong |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2019.489 | Multiparametric MRI-based radiological activity score (RAS) in Thyroid Associated Orbitopathy (TAO) |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2019.007 | Infrared Pupillometry and Eye-tracking as Next-generation Non-Intrusive Means to Identify Subjects Under Influence of Psychoactive Drug and Vision-related Harms |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2020.349 | Early detection and surveillance of COVID-19 infection by non-invasive ophthalmic evaluations |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2020.097 | Efficacy and safety of Intense Pulsed Light (IPL) on dry eye associated with Thyroid Associated Orbitopathy (TAO) |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2014.124 | Novel strategy using peripheral blood mononuclear cells (PBMC) as a rapid diagnosis for Thyroid-Associated Orbitopathy (TAO) | Dr. CHONG Kelvin Kam Lung |
| 2014.129 | Validation of immunophilins FK506-binding proteins (FKBPs) and their autoantibodies in rapid diagnosis of Thyroid associated orbitopathy (TAO) disease progression | Dr. CHONG Kelvin Kam Lung |
| 2014.128 | Standard diagnostic algorithm for dysthyroid optic neuropathy – Systematic application of clinical investigational devices | Dr. CHONG Kelvin Kam Lung |
| 2014.138 | Using topical CSA to control ocular surface inflammation and improves dry eyes in patients with thyroid eye disease | Prof. Chong Kelvin Kam Lung |
| 2024.294 | Supporting orthoptic assessment for moderate-to-severe active Thyroid Eye Disease patients with diplopia | Dr. CHONG Kelvin Kam Lung |
| 2023.528 | SAfe immunomodulation reserVEd for Mild-to-mOderate, REcent-onset TED (SAVE-MORE-TED) - a multi-center, randomized, double-masked, placebo-controlled trial | Dr. CHONG Kelvin Kam Lung |
| 2025.747 | The profile of immune cells in patients with thyroid eye disease | Dr. CHONG Kelvin Kam Lung |
| 2024.588 | Efficacy of Topical Tranexamic Acid on Operative Bleeding in Endoscopic Endonasal Dacryocystorhinostomy: A Multi Center, Double masked, Prospective, Randomized Clinical Trial | Dr. CHONG Kelvin Kam Lung |
| 2025.165 | Explainable AI on ocular surface - from mobile health (mHealth) to mobile eye health (meHealth) | Dr. CHONG Kelvin Kam Lung |
| 2025.426 | ADdiction-Related Eye Assessment and Management (ADREAM) | Dr. CHONG Kelvin Kam Lung |
| 2025.415 | Mixed-reality Immersive Neuro-cognitive-ophthalmic Diagnostic (MIND) platform | Dr. CHONG Kelvin Kam Lung |
| 2025.390 | Perioperative haemostasis, Procedure-related Pain after Physiological or Pharmacological modifications of Local anaesthesia around the Eyes (P4LE) – a double-masked, split-face, active-controlled, pilot randomised clinical trial | Dr. CHONG Kelvin Kam Lung |
| 2022.582 | Efficacy and tolerability of 0.2% hyaluronic acid & 2% ectoin topical eye drops, Vitamin A ointment, and lid wipe in post-COVID Meibomian Gland Dysfunction (MGD): a 3-arm randomized clinical trial |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2022.199 | Deep learning and radiomics algorithm of neuroimaging for TED in Hong Kong – A territory-wide study from the HADCL |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2020.478 | Hong Kong IgG4-Related Disease Registry |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2021.271 | Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress (VIEW) therapies for meibomian gland dysfunction - a multicentre, randomized, assessor-masked, active-controlled clinical trial |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2023.352 | Ocular surface damage and alteration in microbiome among cocaine and ice users - a prospective observational study for their health enhancement | Dr. CHONG Kelvin Kam Lung |
| 2020.465 | Ocular microenvironment and mucosal microbiota reveal COVID-19 severity, transmissibility and model drug responses |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2021.473 | Mapping the Thyroid Associated Orbitopathy (TAO) Genes by Whole Genome Sequencing (WGS) | Dr. CHONG Kelvin Kam Lung |
| 2023.422 | A Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Determine the Safety, Tolerability, Preliminary Efficacy, Immunogenicity, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients with Pulmonary Fibrosis or Thyroid Eye Disease | Prof. CHONG Kelvin Kam Lung |
| 2023.191 | Site-specific microbiome in common lacrimal gland disorders | Dr CHONG Kelvin Kam Lung |
| 2026.075 | Monitoring the antiviral effectiveness against acute severity and post-COVID sequelae following SARS-CoV-2 infection in a community outpatient setting | Prof. CHONG Marc Ka Chun |
| 2025.408 | Combined treatment for long COVID: cohort study | Dr. CHONG Marc Ka Chun |
| 2025.011 | Cost-effectiveness of nirmatrelvir/ritonavir in treating long COVID | Dr. CHONG Marc Ka Chun |
| 2025.687 | Hourly effects of ambient heat and cold on Accident and Emergency visits in influenza and non-influenza seasons | Prof. CHONG Marc Ka Chun |
| 2023.622 | Projecting the impact of population aging on mortality attributable to extreme heat | Dr. CHONG Marc Ka Chun |
| 2025.477 | A pilot study using retinal image analysis to detect TCM body constitution and well-being level | Prof. CHONG Marc Ka Chun |
| 2019.440 | Development of objective measure of psychotropic substances abuse using Automatic Retinal Image Analysis (ARIA) |
Dr. CHONG Marc Ka Chun 莊家俊 |
| 2020.263 | Factors associating with participation and adherence of cardiac rehabilitation programme among coronary heart disease patients | Ms. CHONG Mei Sin |
| 2020.621 | Effectiveness of Technology-assisted Interventions in Hybrid Cardiac Rehabilitation (TecHCR) among Coronary Heart Disease Patients | Ms. CHONG Mei Sin |
| 2023.380 | Evaluation of the Hong Kong Genome Project (HKGP) | Dr. CHONG Shuk Ching |
| 2017.135 | Clinical classification of osteogenesis imperfecta and genotype-phenotype correlation in local Chinese patients |
Dr. CHONG Shuk Ching 莊淑貞醫生 |
| 2019.464 | Retrospective study of mitochondrial disorders in Hong Kong |
Dr. CHONG Shuk Ching 莊淑貞 |
| 2019.293 | Metabolomics profiling study for patients with citrin deficiency |
Dr. CHONG Shuk Ching 莊淑貞 |
| 2019.685 | Parental attitudes on newborn genetics screening program in Hong Kong |
Prof. CHONG Shuk Ching 莊淑貞 |
| 2025.203 | Application of whole genome sequencing with integrative multi-omics to advance diagnosis of rare diseases | Dr. CHONG Shuk Ching |
| 2019.182 | Clinical application of whole genome sequencing and transcriptome sequencing technique to reveal the molecular diagnosis of undiagnosed disease |
Dr. CHONG Shuk Ching 莊淑貞 |
Page 84 of 288.